Oncology

Patients with Barrett’s esophagus who also have diabetes are at increased risk for the esophageal disease to progress to dysplasia or cancer…. 

Risk of progression more than doubled….

The intake of metformin has been associated with a decreased incidence of colorectal cancer in patients with type 2 diabetes in several studies but…. 

In contrast to findings from previous studies, the development of breast cancer is not tied to insulin use, a new study says… 

Sugar intake seems to promote the growth and spread of tumors in fruit flies through a few pathways….

This study systemically reviewed randomized controlled trials and observational studies to evaluate whether actual exposure of metformin can be associated with cancer and cancer mortality in type 2 diabetes patients….

The longer patients were treated with metformin after being diagnosed with prostate cancer, the greater their survival rates were, depending on the dose they were given….

According to the European Medicines Agency’s Committee for Medicinal Products for Human Use, current data linking glucagon-like-peptide-1 (GLP-1) agonists to adverse pancreatic events are not adequate….

A registry study affirmed that insulin glargine (Lantus) didn’t significantly raise cancer risk compared with "human" insulin…. 

In a select sample of breast cancer patients, the possible anti-cancer effects of metformin do not significantly increase survival rates….